Illumina is planning to expand operations in China, its biggest market outside of the US, following double-digit growth in the company's revenue there in the past two years. The plan, which comes as the company eyes expansion of its global footprint, will include collaboration with Chinese genome sequencing service companies, particularly startups, said Illumina CEO Francis deSouza.
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.